These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 9630573

  • 1. Expression of fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine.
    Watanabe K, Hashimoto K, Nishimura T, Tsunashima K, Minabe Y.
    Brain Res; 1998 Jun 22; 797(1):135-42. PubMed ID: 9630573
    [Abstract] [Full Text] [Related]

  • 2. Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors.
    Bardgett ME, Henry JD.
    Neuroscience; 1999 Jun 22; 94(1):59-70. PubMed ID: 10613497
    [Abstract] [Full Text] [Related]

  • 3. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area.
    Bontempi B, Sharp FR.
    J Neurosci; 1997 Nov 01; 17(21):8596-612. PubMed ID: 9334431
    [Abstract] [Full Text] [Related]

  • 4. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens.
    Hussain N, Flumerfelt BA, Rajakumar N.
    Neuroscience; 2001 Nov 01; 102(2):391-9. PubMed ID: 11166125
    [Abstract] [Full Text] [Related]

  • 5. Nicotine-induced Fos expression in the nucleus accumbens and the medial prefrontal cortex of the rat: role of nicotinic and NMDA receptors in the ventral tegmental area.
    Schilström B, De Villiers S, Malmerfelt A, Svensson TH, Nomikos GG.
    Synapse; 2000 Jun 15; 36(4):314-21. PubMed ID: 10819909
    [Abstract] [Full Text] [Related]

  • 6. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
    Lee J, Rajakumar N.
    Neuroscience; 2003 Jun 15; 122(3):739-45. PubMed ID: 14622917
    [Abstract] [Full Text] [Related]

  • 7. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
    Ozer H, Ekinci AC, Starr MS.
    Brain Res; 1997 Nov 28; 777(1-2):51-9. PubMed ID: 9449412
    [Abstract] [Full Text] [Related]

  • 8. MK-801 reverses Fos expression induced by the full dopamine D1 receptor agonist SKF-82958 in the rat striatum.
    Nakazato E, Ohno M, Watanabe S.
    Eur J Pharmacol; 1998 Jan 26; 342(2-3):209-12. PubMed ID: 9548387
    [Abstract] [Full Text] [Related]

  • 9. Amantadine induces c-fos in rat striatum: reversal with dopamine D1 and NMDA receptor antagonists.
    Tomitaka S, Hashimoto K, Narita N, Minabe Y, Tamura A.
    Eur J Pharmacol; 1995 Oct 16; 285(2):207-11. PubMed ID: 8566141
    [Abstract] [Full Text] [Related]

  • 10. Nicotine induced c-fos expression in the striatum is mediated mostly by dopamine D1 receptor and is dependent on NMDA stimulation.
    Kiba H, Jayaraman A.
    Brain Res Mol Brain Res; 1994 Apr 16; 23(1-2):1-13. PubMed ID: 7913201
    [Abstract] [Full Text] [Related]

  • 11. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Panagis G, Hildebrand BE, Svensson TH, Nomikos GG.
    Synapse; 2000 Jan 16; 35(1):15-25. PubMed ID: 10579804
    [Abstract] [Full Text] [Related]

  • 12. Sexual dimorphism in the response to N-methyl-D-aspartate receptor antagonists and morphine on behavior and c-Fos induction in the rat brain.
    D'Souza DN, Harlan RE, Garcia MM.
    Neuroscience; 1999 Jan 16; 93(4):1539-47. PubMed ID: 10501478
    [Abstract] [Full Text] [Related]

  • 13. Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors.
    Liste I, Rozas G, Guerra MJ, Labandeira-Garcia JL.
    Brain Res; 1995 Nov 27; 700(1-2):1-12. PubMed ID: 8624698
    [Abstract] [Full Text] [Related]

  • 14. Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE, Strauss JB.
    Brain Res; 1999 May 08; 827(1-2):160-8. PubMed ID: 10320705
    [Abstract] [Full Text] [Related]

  • 15. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S, Hashimoto K, Hattori K, Yuasa S, Iyo M.
    Brain Res; 2004 Jun 11; 1011(1):84-93. PubMed ID: 15140647
    [Abstract] [Full Text] [Related]

  • 16. Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats.
    Harrison AA, Gasparini F, Markou A.
    Psychopharmacology (Berl); 2002 Feb 11; 160(1):56-66. PubMed ID: 11862374
    [Abstract] [Full Text] [Related]

  • 17. Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats.
    Sacaan AI, Menzaghi F, Dunlop JL, Correa LD, Whelan KT, Lloyd GK.
    J Pharmacol Exp Ther; 1996 Feb 11; 276(2):509-15. PubMed ID: 8632316
    [Abstract] [Full Text] [Related]

  • 18. Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease.
    Ishida Y, Todaka K, Kuwahara I, Ishizuka Y, Hashiguchi H, Nishimori T, Mitsuyama Y.
    Brain Res; 1998 Oct 26; 809(1):107-14. PubMed ID: 9795171
    [Abstract] [Full Text] [Related]

  • 19. The nicotinic acetylcholine receptor agonist (+/-)-epibatidine increases FGF-2 mRNA and protein levels in the rat brain.
    Belluardo N, Mudò G, Blum M, Cheng Q, Caniglia G, Dell'Albani P, Fuxe K.
    Brain Res Mol Brain Res; 1999 Dec 10; 74(1-2):98-110. PubMed ID: 10640680
    [Abstract] [Full Text] [Related]

  • 20. Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity.
    Rupniak NM, Patel S, Marwood R, Webb J, Traynor JR, Elliott J, Freedman SB, Fletcher SR, Hill RG.
    Br J Pharmacol; 1994 Dec 10; 113(4):1487-93. PubMed ID: 7889306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.